EORTC protocol 06863

A randomized phase III study of autologous bone marrow transplantation versus intensive consolidation during first complete remission in acute myelogenous leukemia (AML-8A)
Trial StatusAll trial activities ended
DatesDate of activation: 15-Nov-86
Date Step1 close: 09-Jun-94
Date Step2 close: 09-Jun-94
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size316
Number of steps2
Drug
Study StaffRobert A. Zittoun (Study Coordinator) - Assistance Publique - Hôpitaux de Paris - Hotel-Dieu De Paris AP-HP, Paris
Type of cancerAcute Myelogenous Leukemia
Participating GroupsEORTC Leukemia Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section